BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yamazato M, Yanai S, Oizumi T, Eizuka M, Yamada S, Toya Y, Uesugi N, Sugai T, Matsumoto T. Appropriate leucine-rich α-2 glycoprotein cut-off value for Japanese patients with ulcerative colitis. World J Clin Cases 2023; 11(32): 7753-7760 [PMID: 38073694 DOI: 10.12998/wjcc.v11.i32.7753]
URL: https://www.wjgnet.com/2307-8960/full/v11/i32/7753.htm
Number Citing Articles
1
Fatemeh Ojaghi Shirmard, Seyed Morteza Pourfaraji, Behrad Saeedian, Tannaz Bagheri, Abdulrahman Ismaiel, Satohiro Matsumoto, Nastaran Babajani. The usefulness of serum leucine-rich alpha-2 glycoprotein as a novel biomarker in monitoring inflammatory bowel disease: a systematic review and meta-analysisEuropean Journal of Gastroenterology & Hepatology 2025; 37(8): 891 doi: 10.1097/MEG.0000000000002952
2
Katsuyoshi Matsuoka, Fumihito Hirai, Kenji Watanabe, Ryota Hokari, Taku Kobayashi, Masayuki Saruta, Hiroshi Nakase, Takahiro Suzuki, Gakuto Yamazaki, Toshifumi Hibi, Mamoru Watanabe, Tadakazu Hisamatsu. Optimising carotegrast methyl use in ulcerative colitis: patient profiling, predictive biomarkers, and timing of efficacy evaluation (ASPECT study)Journal of Gastroenterology 2025;  doi: 10.1007/s00535-025-02299-9